1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Enrollment increased: 40000 → 80000 participants
Also in this update: Trial sites expanded: 11 → 16 locations
Kirby InstituteNot specified NCT05248555 Registry history of NCT05248555 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-05 | NCT07858526 Optimised Dalbavancin Dosing for Serious Gram-Positive Bacterial Infections | Not Yet Recruiting |
| Phase 2 | 2 | |
| Phase 3 | 3 | |
| Phase 4 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT03855917 | Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus… | Hepatitis C | Recruiting | 2026-07-29 |
| NCT07145736 | Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of… | Onchocerciasis | Recruiting | 2025-11-21 |
| Phase 3 | ||||
| NCT05415267 | Immunosuppression and COVID-19 Boosters | COVID-19 | Recruiting | 2026-02-24 |
| NCT06317051 | Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on… | HIV Infections | Active, Not Recruiting | 2026-07-22 |
| NCT04415424 | Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual… | Neisseria Gonorrheae Infection | Active, Not Recruiting | 2025-03-24 |
| Phase 2 | ||||
| NCT07509112 | Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study | Methamphetamine Use Disorder | Not Yet Recruiting | 2026-06-26 |
| NCT07550595 | Oritavancin for Treatment of Serious Cardiac Infections | Infective Endocarditis | Not Yet Recruiting | 2026-04-29 |
| Not applicable | ||||
| NCT03685045 | ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings | Hepatitis C | Recruiting | 2026-05-14 |
| NCT07790601 | Swabs in Screening for HPV (SWISH) | Anal Cancer | Not Yet Recruiting | 2026-08-27 |
| Not specified | ||||
| NCT05042544 | The Australian HCV Point-of-Care Testing Program | Hepatitis C | Recruiting | 2026-09-28 |
| NCT05248555 | The National Australian HCV Point-of-Care Testing Program - Minimal Dataset | Hepatitis C | Recruiting | 2026-09-28 |
| NCT05713136 | The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal… | Hepatitis C | Recruiting | 2026-09-28 |
| NCT04914611 | Real World Assessment of People Living With Chronic Hepatitis B in Australia | Hepatitis B | Recruiting | 2026-05-19 |
| NCT07858526 | Optimised Dalbavancin Dosing for Serious Gram-Positive Bacterial Infections | Serious Gram-Positive Bacterial Infections | Not Yet Recruiting | 2026-10-05 |
| NCT06220370 | PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for… | Invasive Fungal Infections | Not Yet Recruiting | 2024-02-20 |
| NCT04641013 | Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE) | HIV Infections | Active, Not Recruiting | 2020-11-23 |
Colorectal Cancer (1) · Heart Disease (1)